Insulin Storage Devices Market Size, Share & Trends Analysis Report By Type (Type 1 diabetes, Type 2 diabetes), By Application (Home use, Hospitals and clinics, Pharmaceutical and biotechnology companies, Research and academic institutions, Others), By End Users (Hospitals and clinics, Homecare settings, Pharmaceutical and biotechnology companies and Others), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2031

Region: Global | Format: Word, PPT, Excel | Report Status: Published

Market Overview:

The global insulin storage devices market is estimated to be valued at USD 891.49 million in 2022, and is expected to reach USD 1,680.89 million by 2030, at a CAGR of 8.3% during the forecast period 2023 to 2031.

This growth is attributed to the increasing incidence of diabetes, the rising adoption of advanced insulin delivery devices, and the increasing demand for advanced storage options. Insulated kits are expected to dominate the market in 2019, followed by battery-operated coolers. The market is expected to witness growth in the Asia Pacific region, due to rising disease prevalence and awareness drives for effective use and storage of insulin. The insulin storage devices market is projected to reach multimillion USD by 2031, in comparison to 2023, at an unexpected CAGR during the forecast period.

Hospitals, home care, clinics, and specialty centers are the major consumers of the market, with hospitals being the biggest end-users . The report covers the global market, focusing on key trends, drivers, and restraints and provides a detailed analysis of the market share and growth scenario.

The insulin storage devices market refers to the market for storage and transportation devices used to keep insulin at the correct temperature and maintain its effectiveness. Insulin is a hormone used to treat diabetes, and it must be stored properly to ensure its potency and effectiveness. The global insulin storage devices market is driven by the increasing prevalence of diabetes, particularly in emerging economies. The growing adoption of insulin pumps and pens is also contributing to the growth of the market. Additionally, the increasing number of product launches by key players, focusing on user-friendly and innovative insulin storage devices, is driving the growth of the market.

However, the high cost of insulin storage devices and the lack of awareness about the use of insulin storage devices in developing countries are some of the factors that may hinder the growth of the market. Furthermore, the growing adoption of alternative therapies for diabetes, such as oral medications and non-invasive insulin delivery methods, may also impact the demand for insulin storage devices in the future.

The market is segmented into product type, distribution channel, and region. The product type includes insulin pens, insulin pumps, and insulin syringes. The distribution channel includes retail pharmacies, hospital pharmacies, and online pharmacies. North America dominates the market, followed by Europe, due to the high prevalence of diabetes and high healthcare expenditure in these regions. However, the Asia-Pacific region is expected to witness significant growth in the coming years due to the increasing prevalence of diabetes and the growing adoption of insulin pumps and pens.

Scope of Insulin Storage Devices Market:

This growth is attributed to the increasing incidence of diabetes, the rising adoption of advanced insulin delivery devices, and the increasing demand for advanced storage options. Insulated kits are expected to dominate the market in 2019, followed by battery-operated coolers. The market is expected to witness growth in the Asia Pacific region, due to rising disease prevalence and awareness drives for effective use and storage of insulin. The insulin storage devices market is projected to reach multimillion USD by 2031, in comparison to 2023, at an unexpected CAGR during the forecast period.

Hospitals, home care, clinics, and specialty centers are the major consumers of the market, with hospitals being the biggest end-users . The report covers the global market, focusing on key trends, drivers, and restraints and provides a detailed analysis of the market share and growth scenario.

The insulin storage devices market refers to the market for storage and transportation devices used to keep insulin at the correct temperature and maintain its effectiveness. Insulin is a hormone used to treat diabetes, and it must be stored properly to ensure its potency and effectiveness. The global insulin storage devices market is driven by the increasing prevalence of diabetes, particularly in emerging economies. The growing adoption of insulin pumps and pens is also contributing to the growth of the market. Additionally, the increasing number of product launches by key players, focusing on user-friendly and innovative insulin storage devices, is driving the growth of the market.

However, the high cost of insulin storage devices and the lack of awareness about the use of insulin storage devices in developing countries are some of the factors that may hinder the growth of the market. Furthermore, the growing adoption of alternative therapies for diabetes, such as oral medications and non-invasive insulin delivery methods, may also impact the demand for insulin storage devices in the future.

The market is segmented into product type, distribution channel, and region. The product type includes insulin pens, insulin pumps, and insulin syringes. The distribution channel includes retail pharmacies, hospital pharmacies, and online pharmacies. North America dominates the market, followed by Europe, due to the high prevalence of diabetes and high healthcare expenditure in these regions. However, the Asia-Pacific region is expected to witness significant growth in the coming years due to the increasing prevalence of diabetes and the growing adoption of insulin pumps and pens.

Market Drivers of Insulin Storage Devices:

The insulin storage devices market is driven by several factors, including:

  • Rising prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate, and insulin therapy is often required to manage the condition. This has led to a significant increase in demand for insulin storage devices.
  • Technological advancements: There have been significant technological advancements in insulin storage devices, including the development of smart insulin pens, insulin pumps, and continuous glucose monitoring systems, which have increased the ease of use and convenience of these devices.
  • Growing awareness about insulin therapy: There is a growing awareness among healthcare professionals and patients about the benefits of insulin therapy, which has resulted in increased demand for insulin storage devices.
  • Increasing adoption of insulin pumps: Insulin pumps are becoming increasingly popular among patients with diabetes, as they offer better control of blood glucose levels and greater convenience. This has resulted in increased demand for insulin pump accessories such as infusion sets and reservoirs.
  • Favorable reimbursement policies: Many countries have favorable reimbursement policies for insulin storage devices, which has increased access to these devices for patients with diabetes.
  • Increasing disposable income: The increasing disposable income of individuals in developing countries has led to greater affordability of insulin storage devices, which has resulted in increased demand for these devices.

Overall, these drivers are expected to continue to fuel growth in the insulin storage devices market in the coming years.

Market Trends of Insulin Storage Devices:

This growth is mainly attributed to the increasing prevalence of diabetes, technological advances in insulin storage devices, and rising government initiatives for diabetes awareness.

Insulin delivery systems are becoming increasingly compact, allowing for greater portability and convenience for patients. Many manufacturers are developing pen-type insulin delivery systems that are easier to carry and use. For instance, the InsuPatch is a pen-sized device that contains a syringe, plunger, and insulin supply. This device is designed to accurately monitor insulin levels and is equipped with a digital display that tracks dosage history.

Moreover, manufacturers are also focusing on developing smart insulin storage devices that are connected to mobile devices. These devices allow users to monitor and manage insulin doses through mobile applications. Smart insulin storage devices are also equipped with features such as dose tracking, reminders, and temperature sensing.

The increasing acceptance of digital health solutions and the growth in venture capital investments in digital health companies are also expected to drive the growth of the insulin storage devices market. In addition, the increasing number of clinical trials and the introduction of new products are expected to contribute to the growth of this market.

Market Restraining Factors of Insulin Storage Devices:

The global insulin storage devices market is expected to witness some restraining factors over the forecast period. The high cost of insulin storage devices and the lack of awareness about the types of insulin storage devices are likely to hamper the growth of the market. Additionally, the limited availability of suitable refrigerated insulin storage devices in developing countries can also act as a restraint for the growth of the market.  Despite these factors, the market is expected to grow significantly due to the rising prevalence of diabetes, changing lifestyle habits and increased awareness about diabetes.

Key Segmentation Analysis of Insulin Storage Devices Market:

By Type

The insulin storage devices market is segmented into two major categories namely, type 1 and type 2 diabetic patients.

  • Type 1 diabetes : The type 1 patient segment is expected to dominate the market owing to the rising need for insulin and adoption of delivery and storage devices. According to the American Diabetes Association, around 34.2 million Americans had diabetes in 2018 and the number of working population suffering from diabetes is growing rapidly in the region.
  • Type 2 diabetes : The type 2 patient segment is growing at a robust pace owing to rapid growth in the inpatient numbers. As type 2 diabetes is lifestyle associated condition, most of the patients belong to the adult and working population. Most of these patients prefer long term insulin carrying devices over frequent pharmacy visits. This is expected to boost the demand for insulin storage devices during the forecast period.

By Application

The insulin storage devices market can be segmented by application into the following categories:

  • Home use: Insulin storage devices for home use are designed for individual patients who need to store insulin at home. These devices can range from small, portable coolers to large, refrigerated storage units.
  • Hospitals and clinics: Insulin storage devices used in hospitals and clinics are often larger and more complex than those used for home use. These devices may include refrigerators, freezers, and other specialized storage equipment.
  • Pharmaceutical and biotechnology companies: Insulin storage devices used by pharmaceutical and biotechnology companies are typically designed for research and development purposes. These devices may include specialized temperature-controlled chambers and other equipment.
  • Research and academic institutions: Insulin storage devices used by research and academic institutions are typically designed for laboratory use. These devices may include specialized refrigerators, freezers, and other equipment.
  • Others: Insulin storage devices may also be used in other applications, such as in transportation or in emergency medical services.

Each of these segments has different requirements and needs, and the market for insulin storage devices is likely to continue to grow as the demand for insulin and other diabetes treatments continues to increase.

By End Users

The insulin storage devices market can also be segmented by end users into the following categories:

  • Hospitals and clinics: Insulin storage devices used in hospitals and clinics are designed to store insulin for patients who receive insulin therapy in these settings. These end users may include both inpatient and outpatient settings.
  • Homecare settings: Insulin storage devices used in homecare settings are designed for patients who manage their diabetes at home. These devices may be portable and convenient for patients who need to store insulin on the go.
  • Pharmaceutical and biotechnology companies: Insulin storage devices used by pharmaceutical and biotechnology companies are designed for use in research and development, as well as for storage and transportation of insulin products.
  • Others: Insulin storage devices may also be used by other end users, such as laboratories, research and academic institutions, and emergency medical services.

The market for insulin storage devices is driven by the increasing prevalence of diabetes, the rising demand for insulin therapy, and the need for safe and effective storage and transportation of insulin products. As the demand for insulin and other diabetes treatments continues to grow, the insulin storage devices market is likely to continue to expand, with different end users having different requirements and needs.

The insulin storage devices market can be segmented by region, and the regional snapshots are as follows:

North America: The North American market for insulin storage devices is driven by the high prevalence of diabetes, the increasing adoption of insulin therapy, and the presence of many pharmaceutical and biotechnology companies. The US is the largest market for insulin storage devices in North America.

Europe : The European market for insulin storage devices is driven by the increasing prevalence of diabetes, the growing aging population, and the rising adoption of insulin therapy. The UK, Germany, and France are some of the largest markets for insulin storage devices in Europe.

Asia Pacific : The Asia Pacific market for insulin storage devices is driven by the increasing prevalence of diabetes, the growing healthcare infrastructure, and the rising demand for advanced healthcare technologies. India and China are some of the largest markets for insulin storage devices in the Asia Pacific.

Latin America : The Latin American market for insulin storage devices is driven by the high prevalence of diabetes, the increasing adoption of insulin therapy, and the rising healthcare spending in the region. Brazil and Mexico are some of the largest markets for insulin storage devices in Latin America.

Middle East and Africa : The Middle East and Africa market for insulin storage devices is driven by the increasing prevalence of diabetes, the growing healthcare infrastructure, and the rising demand for advanced healthcare technologies. Saudi Arabia and South Africa are some of the largest markets for insulin storage devices in the Middle East and Africa.

Each region has unique characteristics, such as different healthcare systems, cultural practices, and regulatory frameworks, that can affect the demand for insulin storage devices. These regional snapshots indicate that the market for insulin storage devices is expected to grow globally, driven by the increasing demand for insulin therapy and the need for safe and effective storage and transportation of insulin products.

Key Players Strategies in the Market:

The insulin storage devices market is a rapidly growing sector. With the increasing prevalence of diabetes, the demand for insulin storage devices is expected to increase. Major players in the market are focusing on the development and launch of innovative storage devices to cater to the rising needs of customers.

The key strategies adopted by major players in the insulin storage devices market are product launches, strategic collaborations, and mergers & acquisitions. Companies are also focusing on research and development activities, such as the development of advanced storage devices with user-friendly features, in order to tap into the potential of the market.

Product launches are a major focus for insulin storage device manufacturers. Companies are introducing new products or variants in the market that offer enhanced features and benefits over existing products. For instance, in 2018, Owen Mumford launched a range of insulin storage devices, including a refrigerator, a temperature-controlled bag, and a temperature-controlled box. This product launch is expected to drive market growth.

Strategic collaborations and mergers & acquisitions are also key strategies adopted by players in the insulin storage devices market. For instance, in December 2018, Medtronic announced the acquisition of Patient IO, a software company focused on connected care solutions. The acquisition is expected to bolster Medtronic's presence in the insulin storage devices market. 

Overall, the insulin storage devices market is expected to experience significant growth in the next few years due to increasing prevalence of diabetes and the adoption of innovative storage solutions. Major players in the market are focusing on product launches, strategic collaborations, and mergers & acquisitions in order to gain a competitive edge. Here are some of the major players in the insulin storage devices market include Becton, Dickinson and Company, Roche Diagnostics, Terumo Corporation, Medtronic plc, Tandem Diabetes Care, Inc., Arkray Inc., Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Insulet Corporation, and others. 

List of Companies Profiled:

Here is a list of some of the companies that have been profiled in the insulin storage devices market:

  • Becton, Dickinson, and Company
  • Roche Diagnostics
  • Terumo Corporation
  • Medtronic plc
  • Tandem Diabetes Care, Inc.
  • Arkray, Inc.
  • Sanofi S.A.
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Insulet Corporation
  • Smiths Medical
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Amgen Inc.
  • Johnson & Johnson Services, Inc.
  • Baxter International Inc.
  • Nipro Corporation
  • Ypsomed AG

Key Industry Developments:

Here are some key industry developments in the insulin storage devices market:

Increasing adoption of insulin pumps: Insulin pumps are becoming more popular among patients with diabetes due to their ability to deliver precise insulin doses and improve patient quality of life. This trend is expected to continue in the future, driving demand for insulin storage devices that are compatible with insulin pumps. 

Technological advancements in insulin storage devices: The insulin storage devices market is constantly evolving, with companies developing new and improved products to meet the evolving needs of patients and healthcare providers. For example, some insulin storage devices now have features such as temperature control, connectivity to mobile apps, and automatic dose tracking.

Increasing awareness of diabetes management: Governments and healthcare organizations are increasingly focusing on diabetes management and prevention, which is driving demand for insulin storage devices. This trend is particularly strong in developing countries where the prevalence of diabetes is increasing rapidly.

Strategic partnerships and collaborations: Many companies in the insulin storage devices market are forming strategic partnerships and collaborations to expand their product portfolios and reach new markets. For example,

  • In 2020, Becton, Dickinson and Company announced a partnership with the JDRF T1D Fund to develop and commercialize a novel insulin infusion set. Increasing investment in research and development: Companies in the insulin storage devices market are investing heavily in research and development to develop new and innovative products. This trend is expected to continue in the future, as companies seek to stay competitive and meet the evolving needs of patients and healthcare providers.
  • In July 2022, Godrej Appliances, an Indian multinational conglomerate, announced the launch of a new product range to provide new cooling solutions for insulin storage. Godrej InsuliCool and Godrej InsuliCool were launched to provide diabetic patients with better storage for their insulin.
  • In 2020, Abbott and Insulet Corporation agreed to integrate Abbott's glucose-sensing technology with Insulet's next-generation tubeless system, the Omnipod HorizonT Automated Insulin Delivery (AID) System, to provide personalized automated insulin delivery and care. 

These key industry developments highlight the dynamic and rapidly evolving nature of the insulin storage devices market, and the need for companies to continuously innovate and evolve to remain competitive and meet the changing needs of their customers.

Report Coverage:

The report will cover the qualitative and quantitative data on the insulin storage devices market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations:

Study Period

2023-31

Base Year

2022

Estimated Forecast Year

2023-31

Growth Rate

CAGR of 8.3% from 2023 to 2031.

Segmentation

By Type, By Application, By End User, By Region

Unit

USD Million

By Type

  • Type 2 diabetes
  • Type 2 diabetes

 By Application

  • Home use
  • Hospitals and clinics
  • Pharmaceutical and biotechnology companies
  • Research and academic institutions
  • Others

 By End Users

  • Hospitals and clinics
  • Homecare settings
  • Pharmaceutical and biotechnology companies
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
  • LAMEA (Latin America, Middle East, Africa)

Frequently Asked Questions

  • How much the global the insulin storage devices Market valued?

    The global insulin storage devices market was valued at approximately at USD 891.49 million in 2022, according to market research reports. However, it is important to note that the market value can vary based on factors such as the type of insulin storage device, the end user, and the region of operation.

  • Which region has the largest share in 2021 for the global the insulin storage devices Market?

    North America is the region with the largest share in 2021 for the global insulin storage devices market. According to Regional Insights, North America accounted for the largest revenue share of 37.5% in 2021. The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the market

  • What are the driving factors for the market?

    The key factors driving the market are the rising prevalence of diabetes and the increasing adoption of advanced insulin delivery devices. Furthermore, rising awareness drives for effective use and storage of insulin, as well as new product launches and acquisitions are expected to flourish the market . The COVID-19 pandemic is also having a significant impact on the insulin storage devices market .

  • Which is the leading segment in the global market?

    Insulated kits are the leading segment in the global insulin storage devices market, accounting for a majority of the market share. This segment is expected to expand at a CAGR of 8.3% during the forecast period, from 2023 to 2031. Rising adoption of insulated kits for storing and transporting insulin is likely to propel the segment growth. Furthermore, the rising prevalence of diabetes and the increasing awareness about the importance of safe and effective insulin storage is anticipated to drive the demand for insulated kits during the forecast period.

  • What are the major players in the market?

    The leading players in the insulin storage devices market are ReadyCare, LLC; DISIONCARE; Medicool; Tawa Outdoor; Cooluli; Arkray, Inc.; Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), The key factors driving the growth of the market include the acceptance of advanced insulin delivery devices, the increase in cases of diabetes worldwide, and the surge in usage in hospitals and clinics .

  • PUBLISHED ON : June, 2022
  • BASE YEAR : 2022
  • STUDY PERIOD : 2020-2032
  • COMPANIES COVERED : 20
  • COUNTRIES COVERED : 25
  • NO OF PAGES : 198

Want to Review Complete Market Research Report

 $2145
 $3245
  $4745

Budget constraints? Get in touch with us for special pricing


Customize this Report

  • Buy specific segmentations (By Market Vertical, By Product Type) of this report
  • Buy specific region/country level reports
  • Request for Product Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • 20+ Company Profiles based on Project Requirement
  • Regulatory Analysis & Case Studies for Marketing Review
  • Competitive Landscape Analysis as per Client Requirement
  • Total Report Customization with Research Team Consultation
  • Why Choose Intellectual Market Insights?
  • Regional and Country Analysis
  • Parent/Child Market Analysis
  • SWOT analysis
  • Real-Time Market Attractiveness Index
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Product and penetration rate of segments. Policies and regulations analysis
  • Profiles of key companies operating in the market
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Supply and Demand analysis
  • Financial Overview of Companies
  • Primary research (conducting interviews with CXO levels)
  • Marketing Survey
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization